Paxlovid Prescribing – Navigating Uncertainties

Gain valuable insights and practical knowledge on how to manage challenges and uncertainties when prescribing medication.




This is a recording of a live webinar held on December 21, 2022

This webinar will provide an up-to-date overview of the evidence for nirmatrelvir/ritonavir (Paxlovid) in the treatment of COVID-19 infection. It will explain the process for prescribing, discuss the assessment of the risk of progression to severe illness, the management of drug interactions. A panel of expert prescribers will discuss the nuances and challenges that prescribers face when prescribing medication.

This webinar is supported by an education grant from Pfizer Canada ULC


Daniel Landry, BScPharm
Jen Belcher
VP Membership & Strategic Initiatives, OPA